Newsbenzinga
Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug
· Published
Article summary
FDA approves Sanofi’s Sarclisa Escena, the first subcutaneous multiple myeloma treatment administered via a hands-free on-body injector.
An excerpt from the original article.
Comments —
Loading comments…